Extended-release oral systems will revolutionize current clinical-care models and maximize effective treatment for a wide range of diseases in a variety of clinical settings.
Giovanni Traverso & Robert Langer
Despite decades of scientific efforts to develop extended drug release technologies, the current oral formulations on the market only extend therapeutic serum delivery to 12-24 hours. The Lyndra team -- comprised of MIT and Harvard scientists and physician scientists -- has for the first time developed a technology that extends oral drug delivery beyond one week.
Lyndra envisions a world in which patients realize the full potential benefit of their medical care and where the overall burden on the healthcare system is reduced.
Kendall Square — the Cambridge, Mass., hub of biotech, pharma, and MIT — is a hard place to pick just three people to keep an eye on. So much goes on there that affects the greater life science industry: Deals are struck, drugs are discovered, companies are formed — and all that happens within walking distance.